{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T09:27:05Z","timestamp":1793957225765,"version":"4.8.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007059","name":"Palack\u00fd University Olomouc","doi-asserted-by":"publisher","award":["IGA_LF_2026_007"],"award-info":[{"award-number":["IGA_LF_2026_007"]}],"id":[{"id":"10.13039\/501100007059","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.msard.2026.107951","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:23:53Z","timestamp":1790609033000},"page":"107951","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cerebrospinal fluid and serum cytokine and CXCL13 profiles in clinically isolated syndrome"],"prefix":"10.1016","volume":"115","author":[{"given":"M\u00e1ria","family":"Czak\u00f3ov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Rous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matou\u0161","family":"Rous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Peter","family":"Hartung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Vyslou\u017eilov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka","family":"Perecov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ond\u0159ej","family":"Sobek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.msard.2026.107951_bib0001","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.humimm.2020.02.009","article-title":"The action of TH17 cells on blood brain barrier in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"81","author":"Balasa","year":"2020","journal-title":"Hum. Immunol."},{"issue":"16","key":"10.1016\/j.msard.2026.107951_bib0002","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168370","article-title":"Reviewing the significance of blood-brain barrier disruption in multiple sclerosis pathology and treatment","volume":"22","author":"Balasa","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"10076","key":"10.1016\/j.msard.2026.107951_bib0003","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S0140-6736(16)30959-X","article-title":"Diagnosis of multiple sclerosis: progress and challenges","volume":"389","author":"Brownlee","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.msard.2026.107951_bib0004","doi-asserted-by":"crossref","DOI":"10.1177\/17562864211030664","article-title":"Predicting conversion to multiple sclerosis in patients with radiologically isolated syndrome: a retrospective study","volume":"14","author":"Chaloulos-Iakovidis","year":"2021","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"11","key":"10.1016\/j.msard.2026.107951_bib0005","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1177\/1352458519864933","article-title":"Infratentorial and spinal cord lesions: cumulative predictors of long-term disability?","volume":"26","author":"Dekker","year":"2020","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2026.107951_bib0006","article-title":"Fluid biomarkers in multiple sclerosis: from current to future applications","volume":"44","author":"Di Filippo","year":"2024","journal-title":"Lancet Reg. Health - Eur."},{"issue":"3","key":"10.1016\/j.msard.2026.107951_bib0007","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00415-025-12907-6","article-title":"CSF biomarkers of B-cell activation in multiple sclerosis: a clinical perspective","volume":"272","author":"Di Sabatino","year":"2025","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2026.107951_bib0008","series-title":"StatPearls","article-title":"Interleukin","author":"Harris","year":"2026"},{"issue":"3","key":"10.1016\/j.msard.2026.107951_bib0009","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/WCO.0000000000000699","article-title":"Diagnosis of multiple sclerosis: revisions of the McDonald criteria 2017 \u2013 continuity and change'","volume":"32","author":"Hartung","year":"2019","journal-title":"Curr. Opin. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2026.107951_bib0010","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5507\/bp.2023.002","article-title":"Cerebrospinal fluid neurofilament light chains and CXCL13 as predictive factors for clinical course of multiple sclerosis","volume":"167","author":"Hradilek","year":"2023","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub."},{"issue":"6","key":"10.1016\/j.msard.2026.107951_bib0011","doi-asserted-by":"crossref","DOI":"10.3390\/life15060859","article-title":"Cytokine gene expression and treatment impact on MRI outcomes in Jordanian patients with multiple sclerosis","volume":"15","author":"Khdair","year":"2025","journal-title":"Life"},{"key":"10.1016\/j.msard.2026.107951_bib0012","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-65154-8","article-title":"Longitudinal proteomic profiling of cerebrospinal fluid in untreated multiple sclerosis defines evolving disease biology","volume":"16","author":"Kosa","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.msard.2026.107951_bib0013","article-title":"Interaction between Th17 and central nervous system in multiple sclerosis","volume":"43","author":"Lai","year":"2025","journal-title":"Brain Behav. Immun. - Health"},{"issue":"1","key":"10.1016\/j.msard.2026.107951_bib0014","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s12035-022-03060-6","article-title":"CSF CXCL13 and Chitinase 3-like-1 levels predict disease course in relapsing multiple sclerosis","volume":"60","author":"Lucchini","year":"2023","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.msard.2026.107951_bib0015","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/brain\/awm038","article-title":"Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology","volume":"130","author":"Magliozzi","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.msard.2026.107951_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/2727042","article-title":"Serum and cerebrospinal fluid cytokine biomarkers for diagnosis of multiple sclerosis","volume":"2020","author":"Martynova","year":"2020","journal-title":"Mediat. Inflamm."},{"issue":"9","key":"10.1016\/j.msard.2026.107951_bib0017","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S1474-4422(25)00270-4","article-title":"Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria","volume":"24","author":"Montalban","year":"2025","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2026.107951_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.607766","article-title":"Ectopic lymphoid follicles in multiple sclerosis: centers for disease control?","volume":"11","author":"Negron","year":"2020","journal-title":"Front. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2026.107951_bib0019","article-title":"Emerging CSF and serum biomarkers in multiple sclerosis: cytokines, MOG, GFAP, and beyond","volume":"13","author":"Oechtering","year":"2026","journal-title":"Neurol.: Neuroimmunol. Neuroinflammation"},{"issue":"12","key":"10.1016\/j.msard.2026.107951_bib0020","doi-asserted-by":"crossref","DOI":"10.3390\/biom14121541","article-title":"CXCL13 as a biomarker: background and utility in multiple sclerosis","volume":"14","author":"Pachner","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.msard.2026.107951_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2025.106303","article-title":"The CXCL13 index biomarker predicts success or failure of moderate-efficacy disease-modifying therapies in multiple sclerosis: a real-world study","volume":"95","author":"Pachner","year":"2025","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"13","key":"10.1016\/j.msard.2026.107951_bib0022","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241311050","article-title":"The CXCL13 index as a predictive biomarker for activity in clinically isolated syndrome","volume":"24","author":"Pike","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.msard.2026.107951_bib0023","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1540263","article-title":"Role of innate immune cells in multiple sclerosis","volume":"16","author":"Prado","year":"2025","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.msard.2026.107951_bib0024","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.it.2023.02.002","article-title":"Multiple sclerosis: role of meningeal lymphoid aggregates in progression independent of relapse activity","volume":"44","author":"Ransohoff","year":"2023","journal-title":"Trends Immunol."},{"issue":"11","key":"10.1016\/j.msard.2026.107951_bib0025","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13112590","article-title":"Evolving the diagnosis of multiple sclerosis: a new landscape in light of the 2024 McDonald criteria","volume":"13","author":"Samara","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.msard.2026.107951_bib0026","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s41232-021-00184-5","article-title":"Interleukin-6: evolving role in the management of neuropathic pain in neuroimmunological disorders","volume":"41","author":"Serizawa","year":"2021","journal-title":"Inflamm. Regen."},{"key":"10.1016\/j.msard.2026.107951_bib0027","article-title":"Th17 cells and inflammation in neurological disorders: possible mechanisms of action","volume":"13","author":"Shi","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2026.107951_bib0028","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.00120","article-title":"IL-6 in the cerebrospinal fluid signals disease activity in multiple sclerosis","volume":"14","author":"Stampanoni Bassi","year":"2020","journal-title":"Front. Cell Neurosci."},{"issue":"2","key":"10.1016\/j.msard.2026.107951_bib0029","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.msard.2026.107951_bib0030","first-page":"14","article-title":"CSF biomarkers in multiple sclerosis: beyond neuroinflammation","volume":"2020","author":"Toscano","year":"2021","journal-title":"Neuroimmunol. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.msard.2026.107951_bib0031","article-title":"The interaction of innate immune and adaptive immune system","volume":"5","author":"Wang","year":"2024","journal-title":"MedComm"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826009867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826009867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T08:42:13Z","timestamp":1793954533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826009867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":31,"alternative-id":["S2211034826009867"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107951","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebrospinal fluid and serum cytokine and CXCL13 profiles in clinically isolated syndrome","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107951","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107951"}}